mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.0008 |
mRNA |
Genentech Cpd 10 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0008 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0008 |
mRNA |
Axitinib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
0.001 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
0.09 |
0.001 |
mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
0.096 |
0.002 |